PORTABILITY OF BIOCHEMICAL MARKERS OF SPERM MATURITY
精子成熟度生化标记物的可移植性
基本信息
- 批准号:6344562
- 负责人:
- 金额:$ 24.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2002-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In each ejaculate there are populations of mature and diminished maturity sperm. The decline of the mature population, which affects male fertility and pregnancy outcome, may be measured by sophisticated objective biochemical methods which, at the present time, are available only in a few academic centers. The goal of the present project, in line with the goals of the RFA, is the introduction of biochemical markers in addition to the conventional semen profile, in the monitoring of potential changes in sperm maturity, due to male reproductive toxicity. The accessibility of assays will be facilitated by kits usable at the exposure sites, or by conservation of sperm for transport to a central laboratory. Three paradigms are considered: 1) Semen preparation on site and shipping the samples to a central laboratory; 2) Performance of some tests on-site and shipping semen for others 3) Home collection by subjects and shipping of semen. The specific aims are structured accordingly. First, in the first year we will develop the preservation and shipping of samples for tests routinely used in our laboratory: sperm creatine kinase (CK)-activity, CK-M isoform ratio, and CK- immunostaining for CK-B in order to highlight immature sperm, and for CK-M in order to demonstrate CK-M expression in mature sperm. We will also introduce, on sperm slides sent to us the morphometric probes of sperm maturity, including sperm tail length, tail/head ratio, and midpiece area and shape. Second, in further tests, aspects of the portability need development: sperm binding to hyaluronic acid(HA)-beads indicating maturity, DNA nick translation and the single sperm DNA comet assay, which highlight sperm DNA fragmentation, a known cause of male infertility and increased rates of pregnancy loss. Third, in response to this RFA, we are developing new assessment approaches: optimization of semen shipping in conditions, study of sperm viability with visible wavelength stains, preservation of the proportion of viable sperm at time of ejaculation, CK-M antibody coupled to chromophores for one-step sperm immunostaining, measurement of CK-M directly in semen by a sandwich immuno-assay. Because reproductive toxicity may selectively affect various features of sperm maturation and fertility, we propose to test the same sperm with more than one marker. Examples in preliminary results: HAbead-binding and CK- immunocytochemistry, HAbead-binding and viability DNA nick translation and tail/head ratio, aniline blue chromatin assay and CK-staining. We will identify and make accessible the most effective and practical methods, in order to simplify the monitoring of reproductive toxicity.
在每一次射精中都有成熟度和成熟度降低的精子。影响男性生育力和妊娠结局的成熟人口的下降,可以通过复杂的客观生化方法来衡量,目前只有少数几个学术中心有这种方法。根据RFA的目标,本项目的目标是在常规精液图谱的基础上引入生化标记物,以监测由于男性生殖毒性导致的精子成熟度的潜在变化。通过在暴露地点使用试剂盒或保存精子以便将精子运送到中心实验室,将促进分析的可及性。考虑了三种模式:1)现场精液准备,并将样本运送到中心实验室;2)现场进行一些测试,并为其他测试运送精液;3)受试者在家收集精液,并运送精液。具体的目标是相应地构建的。首先,在第一年,我们将发展样品的保存和运输,用于我们实验室常规的测试:精子肌酸激酶(CK)活性、CK-M亚型比率,以及CK-B的CK-B免疫染色以突出未成熟精子,以及CK-M的CK-M以显示成熟精子中CK-M的表达。我们还将在寄给我们的精子载玻片上介绍精子成熟度的形态测量探针,包括精子尾长、尾头比、中段面积和形状。其次,在进一步的测试中,可携带性的一些方面需要开发:精子与透明质酸(HA)珠子的结合,DNA缺口翻译和单精子DNA彗星试验,这些试验突出了精子DNA碎片,这是男性不育和妊娠失败率增加的已知原因。第三,针对这种RFA,我们正在开发新的评估方法:优化精液运输条件,用可见波长染色研究精子存活率,保存射精时精子存活的比例,将CK-M抗体与生色团偶联一步法精子免疫染色,用夹心免疫分析法直接测定精液中的CK-M。由于生殖毒性可能选择性地影响精子成熟和生育的各种特征,我们建议用多个标记检测同一精子。初步结果中的例子:HAbead结合和CK免疫细胞化学,HAbead结合和活性DNA缺口平移和尾头比,苯胺蓝染色质分析和CK染色。我们将确定并提供最有效和实用的方法,以简化对生殖毒性的监测。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABOR B HUSZAR其他文献
GABOR B HUSZAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABOR B HUSZAR', 18)}}的其他基金
PORTABILITY OF BIOCHEMICAL MARKERS OF SPERM MATURITY
精子成熟度生化标记物的可移植性
- 批准号:
6446031 - 财政年份:1999
- 资助金额:
$ 24.06万 - 项目类别:
PORTABILITY OF BIOCHEMICAL MARKERS OF SPERM MATURITY
精子成熟度生化标记物的可移植性
- 批准号:
6088681 - 财政年份:1999
- 资助金额:
$ 24.06万 - 项目类别:
SPERM CREATINE PHOSPHOKINASE--A PROBE OF MALE FERTILITY
精子肌酸磷酸激酶--男性生育力的探针
- 批准号:
3432445 - 财政年份:1992
- 资助金额:
$ 24.06万 - 项目类别:
SPERM CREATINE PHOSPHOKINASE--A PROBE OF MALE FERTILITY
精子肌酸磷酸激酶--男性生育力的探针
- 批准号:
2291466 - 财政年份:1992
- 资助金额:
$ 24.06万 - 项目类别:
SPERM CREATINE PHOSPHOKINASE--A PROBE OF MALE FERTILITY
精子肌酸磷酸激酶--男性生育力的探针
- 批准号:
3432444 - 财政年份:1992
- 资助金额:
$ 24.06万 - 项目类别:
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Fellowship
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Collaborative R&D
膵癌腫瘍内線維化に着目した術前化学療法効果予測に関する画像biomarkerの確立
建立预测胰腺癌瘤内纤维化术前化疗效果的影像生物标志物
- 批准号:
24K18824 - 财政年份:2024
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
- 批准号:
10073169 - 财政年份:2023
- 资助金额:
$ 24.06万 - 项目类别:
Collaborative R&D














{{item.name}}会员




